Dr. Kiaei has extensive experience in therapeutic development and pre-clinical drug discovery in neurodegenerative diseases. He is responsible for overall leadership, experimental design, implementation, and daily supervision of all aspects of the projects.
Dr. Sharifi is a Pharmacist, (First Moscow State Medical University) and he earned his MPhil and PhD degrees in computational chemistry at Medway School of Pharmacy, the University of Kent (England).
In 2015, he was invited to join the US-FDA as postdoctoral fellow at Biochemical Toxicology and Systems Biology divisions. In 2017, Dr. Sharifi was recruited by Spektron Systems, LLC., (a drug discovery company) that he advanced the company with drug-design and computational chemistry approaches to improve potency, selectivity, and ADME properties while minimizing toxicological risk of novel drug candidates.
Dr. Varughese is a professor in the department of Physiology and Biophysics, College of Medicine, University of Arkansas for Medical Sciences. His laboratory focuses on the structure elucidation of protein molecules using crystallographic techniques. Additionally, he uses structure-based computational techniques to identify novel therapeutic compounds for various targets.
Dr. Jerry A. Darsey is currently director for the Center for Molecular Design and Development and a Professor in the Department of Chemistry at the University of Arkansas at Little Rock. He is inventor or co-inventor on seven patents issued by the Unites States Patent and Trademark office and have authored or co-authored approximately 150 manuscripts in the fields of molecular modeling, neural network simulations, conformational modeling of polymers and proteins, and Monte-Carlo modeling, books, on applications of neural networks to molecular and biomolecular systems. His research interests are primarily in computer modeling techniques of atomic and molecular systems for the elucidation of their chemical and physical properties, but also interested in bioinformatics and medical applications. His research in drug design uses techniques pioneered in his laboratory that involve artificial intelligence procedures and quantum mechanical simulations.